Pertuzumab 600mg/10ml / Trastuzumab 600mg/10ml solution for injection vials
NHS hospitals in England used £252,399,324 of indicative cost of Pertuzumab 600mg/10ml / Trastuzumab 600mg/10ml solution for injection vials in the 12 months to April 2026, about 1.0% of all hospital medicines spend. That is up 5.3% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Pertuzumab 600mg/10ml / Trastuzumab 600mg/10ml solution for injection vials: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Pertuzumab 600mg/10ml / Trastuzumab 600mg/10ml solution for injection vials most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| The Clatterbridge Cancer Centre Nhs Ft | £16,406,712 |
| The Christie Nhs Foundation Trust | £14,855,019 |
| Sheffield Teaching Hospitals Nhs Trust | £6,785,492 |
| The Royal Marsden Nhs Foundation Trust | £6,760,173 |
| Barts Health Nhs Trust | £5,411,032 |
| Nottingham University Hospitals Trust | £5,378,479 |
| Royal Surrey County Hosp Nhs Found Trust | £4,973,375 |
| East And North Hertfordshire Nhs Trust | £4,886,567 |
| Royal Free London Nhs Foundation Trust | £4,846,780 |
| Univ Hpl B/Ham Nhs Foundation Trust | £4,792,525 |
The primary-care picture
Pertuzumab is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Pertuzumab medicine page.